Skip to content

Clinical trials

Neoplasms by Site trials in Hong Kong

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms by Site Country / region: Hong Kong Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20101
20142
20161
20173
20191

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Active, not recruiting1
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche2
AVEO Pharmaceuticals, Inc.1
Abbott1
Celgene1
Eli Lilly and Company1
Imunon1
Sumitomo Pharma America, Inc.1
Turning Point Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms9
Neoplasms by Site9
Digestive System Neoplasms6
Neoplasms by Histologic Type6
Adenocarcinoma5
Carcinoma5
Digestive System Diseases5
Neoplasms, Glandular and Epithelial5
Carcinoma, Non-Small-Cell Lung4
Endocrine Gland Neoplasms4

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.